Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medici
about
Study to Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of AZD9291, in Patients With EGFR Positive Non-small Cell Lung Cancer. Patients Will be Chosen From Those Who Have Already Been Prescribed an EGFR TKI Medici
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study to Assess the Effect of ...... Prescribed an EGFR TKI Medici
@en
type
label
Study to Assess the Effect of ...... Prescribed an EGFR TKI Medici
@en
prefLabel
Study to Assess the Effect of ...... Prescribed an EGFR TKI Medici
@en
P17
P4844
P1476
A Phase I, Open-label, Non-ran ...... Has Progressed on an EGFR TKI
@en
P3098
NCT02157883
P580
2014-11-06T00:00:00Z
P582
2015-04-03T00:00:00Z